Церебральный венозный тромбоз как осложнение COVID-19: клинические и лечебно-диагностические аспекты (обзор)

Литература:
1. Latreille Е, Warren LL. Interactions of influenza and SARS-CoV-2 with the lung endothelium: Similarities, differences, and implications for therapy. Viruses 13.2. 2021 ;161. URL: https://doi.org/10.3390/v13020161 (15 Dec 2024).
2. Fontanet A, Autran B, Una B, et al. SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet. 2021 ;397(10278):952-4. DOI:10.1016/S0140-6736(21 )00370-6
3. Lai A, Ahmed N, Maqsood A, et al. COVID-19 Omicron-another deadly dilemma. Altamash Journal of Dentistry and Medicine. 2022;1(1):1-5. DOI:10.13140/RG.2.2.14113.28006
4. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bof origin. Nature. 2020;579(7798):270-3. DOI:10.1038/s41586-020-2012-7
5. Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemic. Lancet. 2021; 398(10317):2126-8. DOI:10.1016/S0140-6736(21)02758-6
6. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020;383(2): 120-8. DOM0.1056/NEJ-Moa2015432
7. Nicolai L, Leunig A, Brambs S, et al. Vascular neutro-philic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia. J Thromb Haemost. 2021;19(2):574-81. DOI:10.1111/jth.15179
8. Romoli M, Jelcic I, Bernard-Valnet R, et al. Infectious disease panel of the European Academy of Neurology. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details. Eur J Neurol. 2020;27(9):1712-26. DOI:10.1111/ene.14382
9. Fifi JT, Mocco J. COVID-19 related stroke in young individuals. Lancet Neurol. 2020;19(9):713-5. DOI:10.1016/S1474-4422(20)30272-6
10. Bikdeli B, Madhavan MV, Jimenez D.etal. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950-73. DOI:10.1016/j. jacc.2020.04.031
11. Ulivi L, Squitieri M, Cohen H, et al. Cerebral venous thrombosis: A practical guide. Pract Neurol. 2020;20(5):356-67. DOI:10.1136/practneurol-2019-002415
12. Рамазанов Г.Р, Коригова X.B., Петриков ОС. Диагностика и лечение церебрального венозного тромбоза. Журнал им. НВ Склифосовского Неотложная медицинская помощь. 2021 ;10(1):122-34. DOM0.23934/2223-9022-2021-10-1-122-134
13. Максимова М.Ю., Дубовицкая Ю.И., Брюхов В.В., Кротенкова М.В. Диагностика тромбоза мозговых вен и венозных синусов. РМЖ. 2017;21:1595-601. DOI :10.22328/2079-5343-2019-10-1-26-32
14. Garcia-Azorin D, Monje MHG, Gonzalez-Garcia N, et al. Presence of red flags in patients with cerebral venous sinus thrombosis admitted to the emergency department because of headache: A STROBE compliant cohort-study. Medicine (Baltimore). 2020;99(29):e20900. DOI:10.1097/MD.0000000000020900
15. Белова Л.А., Машин В.В., Ситникова А.И., Белов Д.В. Современные представления о факторах риска церебральных венозных тромбозов. Ульяновский медико-биологический журнал. 2020;3:8-20. Belova L.A., Mashin V.V., Sitnikova A.I., Belov D.V Sovremennye predstavleniya о faktorakh riska tserebral'nykh ve-noznykh trombozov. Modern outlooks on risk factors of cerebral venous thrombosis. Ul'yanovskiy Mediko-Biologicheskiy Zhurnal. 2020;3:8-20. Belova L.A., Mashin V.V., Sitnikova A.I., Belov D.V Sovremennye predstavleniya о faktorakh riska tserebral'nykh ve-noznykh trombozov. Modern outlooks on risk factors of cerebral venous thrombosis. Ul'yanovskiy Mediko-Biologicheskiy Zhurnal. 2020;3:8-20. DOI:10.34014/2227-1848-2020-3-8-20
16. Van Dam LF, van Walderveen MA, Kraft LJ, et al. Current imaging modalities for diagnosing cerebral vein thrombosis -A critical review. Thromb Res. 2020;189:132-9. DOI:10.1016/j. thromres.2020.03.011
17. Kulesh AA. Cerebral venous thrombosis and its hemorrhagic complications. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021 ;13(2):10-8. DOI:10.14412/2074-2711-2021-2-10-18
18. Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 ;42(4): 1158-92. DOI:10.1161/STR.0b013e31820a8364
19. Smith E, Kumar V BET 1: Does a normal D-dimer rule out cerebral venous sinus thrombosis (CVST)? Emerg Med J. 2018;35(6):396-7. DOI:10.1136/emermed-2018-207777.1
20. Ferro JM, Bousser MG, Canhao P, et al.; European Stroke Organization. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10): 1203-13. DOI:10.1111/ene.13381
21. Osteresch R, Fach A, Hambrecht R, et al. ESC-Leitlinien 2019 zu Diagnostikund Management derakuten Lungenembolie. Herz. 2019;44:696-700. DOI:10.1007/s00059-019-04863-5
22. Lee GKH, Chen VH, Tan CH et al. Comparing the efficacy and safety of direct oral anticoagulants with vitamin К antagonist in cerebral venous thrombosis. J Thromb Thrombolysis. 2020;50(3):724-31. DOI:10.1007/s11239-020-02106-7
23. Yaghi S, Shu L, Bakradze E, et al. Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): A multicenter international study. Stroke. 2022;53(3):728-38. DOI:10.1161/STROKEAHA.121.037541
24. Baldini T, Asioli GM, Romoli M, et al. Cerebral venous thrombosis and SARS-CoV-2 infection: A systematic review and meta-analysis. EurJ Neurol. 2021 ;28(10):3478-90. DOI:10.1111/ene.14727
25. Tu TM, Goh C, Tan YK, et al. Cerebral venous thrombosis in patients with COVID-19 infection: A case series and systematic review. J Stroke Cerebrovasc Dis. 2020;29(12): 105379. DOI:10.1016/j.jstrokecerebrovasdis.2020.105379
26. Cavalcanti DD, Raz E, Shapiro M, et al. Cerebral venous thrombosis associated with COVID-19. AJNR Am J Neuroradiol. 2020;41 (8):1370-6. DOM 0.3174/ajnr.A6644
27. Roy-Gash F, De Mesmay M, Devys JM, et al. COVID-19-associated acute cerebral venous thrombosis: Clinical, CT, MRI and EEG features. Crit Care. 2020;24(1):419. DOM0.1186/s13054-020-03225-6
28. Poillon G, Obadia M, Perrin M, et al. Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence? J Neuroradiol. 2021;48(2):121-4. DOI:10.1016/j.neu-rad.2020.05.003
29. Taquet M, Husain M, Geddes JR, et al. Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases. EClinicalMedicine. 2021;39:101061. DOI:10.1016/j.eclinm.2021.101061
30. Al-Mufti F, Amuluru K, Sahni R, et al. Cerebral venous thrombosis in COVID-19: A New York metropolitan cohort study. AJNR Am J Neuroradiol. 2021 ;42(7):1196-200. DOI:10.3174/ ajnr.A7134
31. Ostovan VR, Foroughi R, Rostami M, et al. Cerebral venous sinus thrombosis associated with COVID-19: A case series and literature review. J Neurol. 2021 ;268(10):3549-60. DOI:10.1007/s00415-021-10450-8
32. Hameed S, Wasay M, Soomro BA, et al. Cerebral venous thrombosis associated with COVID-19 infection: An observational, multicenter study. Cerebrovasc Dis Extra. 2021;11(2):55-60. DOI:10.1159/000516641
33. Scutelnic A, van de Munckhof A, Miraclin AT, et al. Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19. Eur Stroke J. 2024;9(3):676-86. DOI:10.1177/23969873241241885
34. Zhang X, Fang K, Lan D, et al. Impact of the COVID-19 pandemic on cerebral venous sinus thrombosis in China: A comparative study. ВМС Neurol. 2025;25(1):17. DOI:10.1186/s12883-025-04019-5
35. Vasaghi Gharamaleki M, Habibagahi M, Hoosh-mandi E, et al. The hospitalization rate of cerebral venous sinus thrombosis before and during COVID-19 pandemic era: A single-center retrospective cohort study. J Stroke Cerebrovasc Dis. 2022;31(7):106468. DOI:10.1016/j.jstrokecerebrovas-dis.2022.106468
36. Panichpisal K, Ruff I, Singh M, et al. Cerebral venous sinus thrombosis associated with coronavirus disease 2019: Case report and review of the literature. Neurologist. 2022;27(5):253-62. DOI:10.1097/NRL.0000000000000390
37. Algarni SA, ALGhasab NS, Alharbi MS, et al. Sex differences and clinical outcomes of patients with coronavirus disease 2019 infection and cerebral venoussinusthrombosis:Asystematic review. ClinApplThromb Hemost. 2024;30:10760296241240748. DOI: 10.1177/10760296241240748

38. Kallel N, Saidani A, Kotti A, et al. Coronavirus disease 19 (COVID-19) and cerebral venous sinus thrombosis (CVST): A case series and review of the literature. Clin Case Rep. 2022;10(8):e6143. DOI:10.1002/ccr3.6143